Showing results (441-450 of 12,110) with videos related to

Sort By:
Pageof 1,211
Neuropharmacology|August 1, 1987
Quinpirole hydrochloride, a potential anti-parkinsonism drugW Koller, G Herbster, D Anderson, et al.
Neuropharmacology|November 14, 2020
Injections of the α-2 adrenoceptor agonist clonidine into the dorsal raphe nucleus increases food intake in satiated ratsRafael Appel Flores, Renata Steinbach, João A B Pedroso, et al.
Neuropharmacology|November 2, 2020
Critical role of TLR4 in uncovering the increased rewarding effects of cocaine and ethanol induced by social defeat in male miceS Montagud-Romero, M D Reguilón, M Pascual, et al.
Neuropharmacology|September 5, 2020
Novel brain permeant mTORC1/2 inhibitors are as efficacious as rapamycin or everolimus in mouse models of acquired partial epilepsy and tuberous sclerosis complexWiebke Theilmann, Birthe Gericke, Alina Schidlitzki, et al.
Neuropharmacology|September 5, 2020
Brainstem prolactin-releasing peptide contributes to cancer anorexia-cachexia syndrome in ratsKeila Navarro I Batista, Marissa Schraner, Thomas Riediger
Neuropharmacology|September 23, 2020
A sphingosine kinase 2-mimicking TAT-peptide protects neurons against ischemia-reperfusion injury by activating BNIP3-mediated mitophagyJia-Li Chen, Xin-Xin Wang, Lei Chen, et al.
Neuropharmacology|September 15, 2020
Diazepam and SL-327 synergistically attenuate anxiety-like behaviours in mice - Possible hippocampal MAPKs specificityAgnieszka Michalak, Artur Wnorowski, Alessia Berardinelli, et al.
Neuropharmacology|September 15, 2020
NLRP3 inflammasome inhibition with MCC950 improves insulin sensitivity and inflammation in a mouse model of frontotemporal dementiaClaire Hull, Ruta Dekeryte, Heather Buchanan, et al.
Neuropharmacology|September 15, 2020
Sevoflurane depresses neurons in the medial parabrachial nucleus by potentiating postsynaptic GABAA receptors and background potassium channelsWei Xu, Lu Wang, Xiang-Shan Yuan, et al.
Neuropharmacology|September 25, 2020
Preclinical characterization of zuranolone (SAGE-217), a selective neuroactive steroid GABAA receptor positive allosteric modulatorAlison L Althaus, Michael A Ackley, Gabriel M Belfort, et al.
Pageof 1,211